Results 11 to 20 of about 4,501 (176)

The Relationship Between Atrial Cardiopathy Biomarkers and Prognosis of Patients With Embolic Stroke of Undetermined Source [PDF]

Frontiers in Cardiovascular Medicine, 2022
ObjectiveTo compare the proportion of atrial cardiopathy in patients with embolic stroke of undetermined source (ESUS) and other non-cardiac strokes, and to evaluate the prognostic value of atrial cardiopathy biomarkers in patients with ESUS.MethodsThis ...
Yuye Ning, Meng Wei, Wenfeng Song, Guogang Luo   +3 more
doaj   +4 more sources

Atrial cardiopathy: a mechanism of cryptogenic stroke. [PDF]

Expert Rev Cardiovasc Ther, 2017
Cryptogenic stroke accounts for approximately 30% of all ischemic strokes. Recently, atrial cardiopathy diagnosed by the presence of one of its serum, imaging, or electrocardiogram biomarkers has been shown to be associated with ischemic stroke, particularly of embolic subtypes.
Yaghi S, Kamel H, Elkind MSV.
europepmc   +6 more sources

Atrial Cardiopathy and Sympatho-Vagal Imbalance in Cryptogenic Stroke: Pathogenic Mechanisms and Effects on Electrocardiographic Markers [PDF]

Frontiers in Neurology, 2018
Recently, atrial cardiopathy has emerged as possible pathogenic mechanism in cryptogenic stroke and many electrocardiographic (ECG) markers have been proposed in order to detect an altered atrial substrate at an early stage. The autonomic nervous system (
Maurizio Acampa, Pietro E. Lazzerini, Giuseppe Martini   +2 more
doaj   +4 more sources

Prognostic significance of atrial cardiopathy in patients with acute ischemic stroke. [PDF]

Eur Stroke J, 2023
Introduction: Whether atrial cardiopathy is associated with stroke prognosis remains unclear. We evaluated the association between atrial cardiopathy markers and outcomes in patients with ischemic stroke using a nationwide prospective registry. Patients and methods: Based on the Third China National Stroke Registry, we evaluated different atrial ...
Wu Y, Yang X, Jing J, Meng X, Li Z, Pan Y, Jiang Y, Yan H, Huang X, Liu L, Zhao X, Wang Y, Li H, Wang Y.   +13 more
europepmc   +5 more sources

Atrial cardiopathy biomarkers and atrial fibrillation in the ARCADIA trial. [PDF]

Eur Stroke J
Background: ARCADIA compared apixaban to aspirin for secondary stroke prevention in patients with cryptogenic stroke and atrial cardiopathy. One possible explanation for the neutral result is that biomarkers used did not optimally identify atrial cardiopathy.
Kamel H, Elkind MS, Kronmal RA, Longstreth WT, Plummer P, Aragon Garcia R, Broderick JP, Pauls Q, Elm JJ, Nahab F, Janis LS, Di Tullio MR, Soliman EZ, Healey JS, Tirschwell DL.   +14 more
europepmc   +5 more sources

Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Atrial fibrillation (AF) is a major, often undetected, cardiac cause of stroke. Markers of atrial cardiopathy, including left atrial enlargement (LAE) or excessive atrial ectopy (EAE) increase the risk of AF and have shown associations with ...
Jodi D. Edwards, Jeff S. Healey, Jiming Fang, Kathy Yip, David J. Gladstone   +4 more
doaj   +4 more sources

P-wave indices and left atrial mechanics as predictors of atrial cardiopathy in embolic stroke of undetermined source [PDF]

Scientific Reports, 2023
Recent research has shed light on the culpability of LA (left atrial) abnormality, in the form of atrial cardiopathy, as an independent risk factor for the development of atrial fibrillation, LA thrombus and subsequent stroke.
Samia Masood, Syed Mohammad Kamil Ashraf, Mohammad Azharuddin Malik, Shagufta Wahab   +3 more
doaj   +2 more sources

History of Cancer and Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Clinical Trial [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Approximately 50% of strokes in patients with cancer are classified as cryptogenic after standard evaluation. Atrial cardiopathy could explain some cancer‐related cryptogenic strokes.
Babak B. Navi, Mitchell S. V. Elkind, Cenai Zhang, David L. Tirschwell, Richard A. Kronmal, Jordan Elm, Joseph P. Broderick, David J. Gladstone, Morin Beyeler, Hooman Kamel, W. T. Longstreth   +10 more
doaj   +2 more sources

Clinical, Imaging, and Atrial Cardiopathy Markers in Ischemic Stroke Subtypes – Clues to a Cardioembolic Source [PDF]

Annals of Indian Academy of Neurology
Background and Objectives: Cryptogenic strokes account for 20%–25% of all ischemic strokes. Although atrial cardiopathy markers are more prevalent in the cryptogenic embolic stroke of undetermined source (ESUS) subgroup than in the nonembolic stroke ...
Sapna Erat Sreedharan, Kakarla Saikiran, SC Chandralekha, CA Athira, PN Sylaja, VT Jissa, Narayanan Namboodiri   +6 more
doaj   +2 more sources

Association of atrial cardiopathy and residual shunt after patent foramen ovale closure in patients experiencing migraine [PDF]

European Journal of Medical Research
Aims Migraine is a prevalent and incapacitating condition. The association between patent foramen ovale (PFO) and migraine-type headaches has been extensively documented.
Xin Gao, Xinxin Zhang, Wei Song, Yan Liu, Ran Guo, Yinong Jiang   +5 more
doaj   +2 more sources